CAS: 1435467-38-1 - 6-(2,5-Dimethoxyphenyl)-3,4-dihydro-4-oxo-2-thioxo-1(2H)-pyrimidineacetamide
Formula:C14H15N3O4S
InChI:InChI=1S/C14H15N3O4S/c1-20-8-3-4-11(21-2)9(5-8)10-6-13(19)16-14(22)17(10)7-12(15)18/h3-6H,7H2,1-2H3,(H2,15,18)(H,16,19,22)
InChI key:InChIKey=LJBUZOGABRDGBR-UHFFFAOYSA-N
SMILES:O=C1C=C(C=2C=C(OC)C=CC2OC)N(C(=S)N1)CC(=O)N
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | PF-06281355 REF: IN-DA009VTSCAS: 1435467-38-1 | 98% | To inquire | Mon 02 Dec 24 |
 | PF-1355 REF: TM-T3511CAS: 1435467-38-1 | 99.77% | To inquire | Tue 03 Dec 24 |
 | PF 06281355 REF: 3D-KHC46738CAS: 1435467-38-1 | Min. 95% | To inquire | Mon 13 Jan 25 |
PF-06281355
CAS:1435467-38-1
Formula:
C14H15N3O4S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
321.3516
Ref: IN-DA009VTS
| 5mg | 191.00 € | ||
| 10mg | 265.00 € | ||
| 25mg | 496.00 € | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 2 Dec 2024
PF-1355
CAS:1435467-38-1
PF-1355 (PF 06281355) is a selective 2-thiouracil mechanism-based MPO inhibitor. PF-1355 is used for treatment …
Formula:
C14H15N3O4S
Purity:
99.77%
Color and Shape:
Solid
Molecular weight:
321.35
Ref: TM-T3511
| 2mg | 35.00 € | ||
| 5mg | 50.00 € | ||
| 10mg | 79.00 € | ||
| 25mg | 114.00 € | ||
| 50mg | 207.00 € | ||
| 100mg | 299.00 € | ||
| 200mg | 427.00 € | ||
| 500mg | To inquire | ||
| 1mL*10mM (DMSO) | 51.00 € |
Estimated delivery in United States, on Tuesday 3 Dec 2024
PF 06281355
CAS:1435467-38-1
PF 06281355 is a novel hypochlorous acid-releasing molecule. It has been shown to induce the …
Formula:
C14H15N3O4S
Purity:
Min. 95%
Molecular weight:
321.35 g/mol
Ref: 3D-KHC46738
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 13 Jan 2025
